11 Best Stocks to Buy for the Next 3 Months According to Hedge Funds

Page 5 of 10

6. Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR)

6-Month Performance: 71.33%

Analyst Upside Potential: 30.70%

Number of Hedge Fund Holders: 32

Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR) is one of the Best Stocks to Buy for the Next 3 Months According to Hedge Funds. On September 2, Patrick Trucchio from H.C. Wainwright reiterated a Buy rating on Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR) with a price target of $80.

The analyst noted the company’s recent deal with Novartis as a strong vote of confidence. The deal brings $200 million upfront, which has the potential to lead to a $2 billion milestone. Trucchio highlighted that this deal validates Arrowhead Pharmaceuticals, Inc.’s (NASDAQ:ARWR) approach to treating CNS diseases and adds important funding without diluting shares.

He also likes the positive results from Ionis Pharmaceuticals’ Olezarsen, which supports Arrowhead’s Plozasiran drug. Both drugs target severe hypertriglyceridemia, a condition linked to pancreatitis risk. Trucchio noted that the company stands out by offering quarterly dosing, which may attract patients and doctors.

Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR) develops medicines that silence genes causing difficult diseases using RNA interference.

Page 5 of 10